Skip to main content
Fig. 2 | Trials

Fig. 2

From: Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trial

Fig. 2

OCT map showing the 4 macular zones used to locate from the fovea and example of a TelCaps’ aggregate. A Color fundus photograph showing circinate exudates. B Late frame ICG (12 mn) showing multiple lesions located within a 1000-μm-diameter circle. Note the contrast between the background fluorescence and the TelCaps and the hypofluorescence of vessels. C ETDRS map showing the 4 macular zones used for TelCaps location. Zone 1: inside a 1-mm-diameter circle (< 500 μm of the center of the macula). Zone 2: inside a 3-mm-diameter circle (between 500 and 1500 μm of the center of the macula). Zone 3: inside a 6-mm-diameter circle (between 1500 and 3000 μm of the center of the macula). Zone 4: outside a 6-mm-diameter circle (beyond 3000 μm of the center of the macula. D Inter-papillomacular area (inside broken lines) represents the exclusion zone for photocoagulation

Back to article page

Trials

ISSN: 1745-6215